ILIAS Biologics

About:

ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules.

Website: http://www.iliasbio.com/eng/

Top Investors: HB Investment, Meritz Securities, Devsisters Ventures, Kiwoom Investment, Timepolio Asset Management

Description:

ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.

Total Funding Amount:

$37.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Daejeon, Taejon-jikhalsi, South Korea

Founded Date:

2015-11-02

Contact Email:

contact(AT)iliasbio.com

Founders:

Chulhee Choi

Number of Employees:

51-100

Last Funding Date:

2020-09-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai